Overview
The Division of Breast Surgery is committed to improving the lives of people at risk for or currently diagnosed with breast cancer. Our faculty lead clinical, translational, and population-based research to improve prevention, diagnosis, treatment, and survivorship. Research efforts span Emory University, Winship Cancer Institute, and Grady Health System.
Research Areas
-
Surgical outcomes and de-escalation
-
Prevention and high-risk breast lesions
-
Health equity and access to care
-
Clinical and translational investigation
-
Patient education and survivorship
-
Precision medicine and biorepository research
Investigators
Tari A. King, MD, FACS, FSSO, FASCO
With a longstanding commitment to breast cancer prevention and risk assessment, her current research examines the clinical and molecular factors that influence the carcinogenic potential of lobular carcinoma in situ (LCIS) and other high-risk breast lesions. Additional work focuses on treatment decision-making in metastatic breast cancer and the implementation of clinical trial findings to improve multidisciplinary care.
Clara Farley, MD, FACS
Focused on advancing personalized breast cancer care, Dr. Farley’s research efforts focus on identifying opportunities for surgical de-escalation that reduce treatment-related morbidity while preserving excellent oncologic outcomes. Her other interests include improving access to care and addressing disparities in breast cancer treatment.
Cletus Arciero, MD, FACS
Advancing precision medicine and multidisciplinary cancer care, his ongoing research explores the role of neoadjuvant therapy, management of ductal carcinoma in situ (DCIS), and disparities in breast cancer outcomes. Leadership of Winship Discovery and participation in ORIEN help support large-scale precision medicine initiatives designed to accelerate cancer research.
Lauren Postlewait, MD, FACS
Driven by a commitment to patient-centered care, her current studies examine strategies to improve patient education and optimize surgical treatment through evidence-based de-escalation approaches. Dr. Postlewait’s interests also include surgical ethics, medical education, and reducing disparities in breast cancer care.
Monica Rizzo, MD, FACS
Spanning both clinical and translational investigation, Dr Rizzo interests include identifying molecular markers that predict cancer risk and guide treatment decisions in breast disease. Her work also focuses on reducing disparities in breast cancer care and improving perioperative glucose management in surgical patients.
Suniah Ayub, MD, MPH, FACS
Committed to improving equitable access to breast cancer care, her research focuses on health disparities, socioeconomic barriers to treatment, and the experiences of immigrant, refugee, and limited English proficiency populations. Dr. Ayub’s work also centers on supporting students from lower-income and first-generation backgrounds.
Toncred Styblo, MD, MS, FACS
Dedicated to advancing surgical innovation in breast cancer care, Dr. Styblo's clinical and translational research has contributed to advances in skin-sparing mastectomy, sentinel lymph node biopsy, oncoplastic surgery, and molecular imaging. These cooperative efforts have helped expand breast conservation options and improve outcomes for patients undergoing breast cancer treatment.